MAPS PBC, rethinking the pharma business model and MDMA-assisted therapy
MAPS PBC, rethinking the pharma business model and MDMA-assisted therapy
Business Trip, a podcast about psychedelic entrepreneurship
Welcome back to Business Trip, a podcast about psychedelic entrepreneurship! 🍄
In Episode 13, we discuss the MAPS PBC and it’s business model for MDMA-assisted therapy. Amy Emerson is the CEO of MAPS Public Benefit Corporation (PBC), which is a fully owned subsidiary of MAPS, and its purpose is to commercialize MDMA-assisted therapy.
In this episode, we discuss:
MAPS’ protocol and strategy behind FDA clinical trial for PTSD
Amy’s views on the state of the industry, patents, and how to prioritize accessibility
The unique business model between MAPS and MAPS PBC
Psychedelics for kids
Listen to the episode here, on Spotify or Apple Podcasts.
When you’re done listening, tweet at us @businesstripfm to share your thoughts!
About Us
Business Trip tells the story of the emerging industry of psychedelics. Each episode features a new company in the field, ranging from biotech startups developing novel compounds, to clinics and retreats for healing, to software companies building tools to power the ecosystem.
Business Trip is produced by Greg Kubin and Matias Serebrinsky — we’re advocates of the healing powers of psychedelic medicine and see a bright future ahead for the industry.
Thanks for listening,
💖 Know someone who would enjoy Business Trip?